Daria V. Gurova

Daria V. Gurova

Auto-generated profile, based on publicly available information

Daria V. Gurova

Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2020 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
NCNatalia V. Chebotareva
Natalia V. Chebotareva
SGsergei Guliaev
sergei Guliaev
TAT. V. Androsova
T. V. Androsova
EPE. N. Popova
E. N. Popova
DGD. V. Gurova
D. V. Gurova
ГВГуляев Сергей Викторович
Гуляев Сергей Викторович
Recent studies have shown a high risk of chronic kidney disease and associated cardiovascular complications in patients with rheumatoid arthritis (RA), which determines the prognosis. However, the prevalence of chronic kidney disease (CKD) in RA has not been established in the Russians. Aim. Study was to examine the prevalence, risk factors and histological variants of CKD in RA. Materials and methods. 180 patients with rheumatoid arthritis were observed in the Tareev clinic of nephrology, for the period from 2014 to 2019 years. Age, gender, duration of RA, drug therapy, ESR, CRP, DAS28, renal function, proteinuria, histological variants were analyzed. Of the common population risk factors for CKD arterial hypertension, weight index, serum lipids and glucose levels were also assessed. Results. The prevalence of CKD in RA was 19.7%. Age, presence and stage of arterial hypertension, an increase in body mass index, as well as high rates of disease activity ESR, CRP, DAS28 score and duration of RA were risk factors of CKD in RA. Age, duration of the disease, stage of AH and hypercholesterolemia were risk factors in multifactorial regression analysis. Amyloidosis was the most common histologic pattern (50.0%), followed by chronic glomerulonephritis (30.4%) and tubulo-interstitial nephritis (19.6%). Among chronic glomerulonephritis mesangial glomerulonephritis was the most frequent. Renal amyloidosis was associated with a duration of RA, presence of systemic symptoms and CRP level. An isolated decrease in GFR of less than 60 ml/min was detected in 31 (36.0%) out of 86 patients. Сonclusion. The risk factors for CKD in patients with RA are activity and duration of the disease In addition to common population factors. Amyloidosis was the most common histologic pattern associated with duration of RA and inflammatory proteins levels.

9 July 2020 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
DGDaria V. Gurova
Daria V. Gurova
NCNatalia V. Chebotareva
Natalia V. Chebotareva
AVAnatoliy A. Vinogradov
Anatoliy A. Vinogradov
ESEkaterina V. Stavrovskaya
Ekaterina V. Stavrovskaya
LLLidia V. Lysenko
Lidia V. Lysenko
We present a case with a rare variant of glomerulonephritis, IgM nephropathy, which occurs mainly with nephrotic syndrome. The clinical features of this variant of kidney damage are characterized; the pathogenetic and the transformation of this form of nephritis into focal segmental glomerulosclerosis are discussed. The development of severe nephrotic syndrome at the beginning of the disease, the formation of secondary steroid resistance have confirmed this hypothesis and have justified the treatment with cyclosporin A aimed at the recovery of the function of the podocyte with remission of nephritis.

15 March 2021 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
LPLiubov A. Ponomareva
Liubov A. Ponomareva
DGDaria V. Gurova
Daria V. Gurova
EPElena N. Popova
Elena N. Popova
NCNatalia V. Chebotareva
Natalia V. Chebotareva
IBInna B. Bondarenko
Inna B. Bondarenko
SMSergey V. Moiseev
Sergey V. Moiseev
We herein report a case of interstitial lung disease secondary to the use of methotrexate in a patient with rheumatoid arthritis. Differential diagnosis between pneumonitis caused by methotrexate in patients treated with basic methotrexate therapy and interstitial pulmonary disease associated with rheumatoid arthritis is based on the clinical examination and instrumental data. The main condition for favorable clinical outcome in all drug-induced lung disease is drug withdrawal, what was proven in our report.